Adocia a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, announced top-line results of...
Read moreSQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray...
Read morePromentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced that it has commenced a...
Read moreSumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada; hereinafter “Sumitomo Dainippon Pharma”) and Angelini S.p.A. announced...
Read moreSwedish Orphan Biovitrum AB (Sobi) has announced that the first patient has been randomised in the phase 3 study anaSTILLs,...
Read moreABIVAX announced the enrolment of the first patient in the ABX464-101 proof-of-concept study of its lead product candidate ABX464 in...
Read moreNovartis announced that the EC approved Tasigna® (nilotinib) for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic...
Read moreWellthy Therapeutics a digital therapeutics company that uses artificial intelligence (AI) and patient centric design to improve patient outcomes is...
Read moreWebflowTM is a comprehensive customer support center which provides PCI clients real-time, 24/7 access to a wide range of reports...
Read moreAstraZeneca announced that the US FDA has approved a new indication for Faslodex (fulvestrant), expanding the indication to include use...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.